1. Can routine data be used to support cancer clinical trials? A historical baseline on which to build: retrospective linkage of data from the TACT (CRUK 01/001) breast cancer trial and the National Cancer Data Repository. Issue 1 (December 2017) Authors: Kilburn, Lucy; Aresu, Maria; Banerji, Jane; Barrett-Lee, Peter; Ellis, Paul; Bliss, Judith Journal: Trials Issue: Volume 18:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Accelerated versus standard epirubicin followed by cyclophosphamide, methotrexate, and fluorouracil or capecitabine as adjuvant therapy for breast cancer in the randomised UK TACT2 trial (CRUK/05/19): a multicentre, phase 3, open-label, randomised, controlled trial. Issue 7 (July 2017) Authors: Cameron, David; Morden, James P; Canney, Peter; Velikova, Galina; Coleman, Robert; Bartlett, John; Agrawal, Rajiv; Banerji, Jane; Bertelli, Gianfilippo; Bloomfield, David; Brunt, A Murray; Earl, Helena; Ellis, Paul; Gaunt, Claire; Gillman, Alexa; Hearfield, Nicholas; Laing, Robert; Murray, Nichol... Journal: Lancet oncology Issue: Volume 18:Issue 7(2017:Jul.) Page Start: 929 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial. Issue 11 (November 2020) Authors: Smith, Ian; Robertson, John; Kilburn, Lucy; Wilcox, Maggie; Evans, Abigail; Holcombe, Chris; Horgan, Kieran; Kirwan, Cliona; Mallon, Elizabeth; Sibbering, Mark; Skene, Anthony; Vidya, Raghavan; Cheang, Maggie; Banerji, Jane; Morden, James; Sidhu, Kally; Dodson, Andrew; Bliss, Judith M; Dowsett, M... Journal: Lancet oncology Issue: Volume 21:Issue 11(2020) Page Start: 1443 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗